MGP

Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0031012 extracellular matrix	IBA GO_REF:0000033	ACCEPT	Summary: MGP is a secreted protein that localizes to the extracellular matrix, specifically associating with the organic matrix of bone and cartilage where it functions to inhibit calcification. This is the primary cellular location for MGP function, supported by IBA phylogenetic evidence and extensive experimental data. Reason: This annotation is well-supported by multiple lines of evidence. MGP is secreted and localizes to the ECM where it carries out its calcification-inhibitory function. The IBA annotation represents phylogenetically conserved localization. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. FUNCTION: Associates with the organic matrix of bone and cartilage. file:human/MGP/MGP-deep-research-perplexity.md Matrix Gla protein is a small secretory protein... MGP acts by binding to calcium ions and calcium-phosphate complexes... This local inhibitory mechanism is fundamentally important because MGP expression occurs at the RNA and protein levels in multiple organs, yet its function in preventing mineralization is tissue-specific and locally regulated file:human/MGP/MGP-deep-research-openai.md See deep research file for comprehensive analysis
GO:0001503 ossification	IEA GO_REF:0000043	ACCEPT	Summary: MGP participates in ossification by inhibiting aberrant bone formation and ectopic calcification. However, MGP also has positive regulatory roles in bone tissue, promoting osteoblast differentiation. The term "ossification" is appropriate but does not capture the complexity of MGP's dual role. Reason: While MGP is best known as an inhibitor of ectopic calcification in soft tissues, it participates in the ossification process in bone. The Keutel syndrome phenotype demonstrates the importance of MGP in regulating proper bone formation. Recent evidence shows MGP also promotes osteoblast differentiation through Wnt signaling, suggesting context-dependent functions in ossification. Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. PMID:9916809 Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification... Mglap-deficient mice (Mglap-/-) have been reported to have inappropriate calcification of cartilage. file:human/MGP/MGP-deep-research-perplexity.md In skeletal tissues, MGP functions as a positive regulator of osteoblast differentiation and bone formation... overexpression of MGP in osteoblast-like cells promotes cell proliferation, differentiation, and mineralization... MGP upregulates components of the Wnt/β-catenin signaling pathway
GO:0005509 calcium ion binding	IEA GO_REF:0000002	ACCEPT	Summary: MGP binds calcium ions with high affinity through its five gamma-carboxyglutamic acid (Gla) residues, which are produced by vitamin K-dependent carboxylation. This calcium binding is essential for MGP's calcification-inhibitory function and represents the core molecular function of the protein. Reason: Calcium ion binding through Gla residues is the fundamental molecular function that enables MGP's biological activity. The Gla domain contains five glutamic acid residues that undergo vitamin K-dependent gamma-carboxylation, creating high-affinity calcium binding sites. This is supported by structural and functional studies showing calcium binding induces conformational changes necessary for MGP function. Supporting Evidence: file:human/MGP/MGP-uniprot.txt PTM: Requires vitamin K-dependent gamma-carboxylation for its function. SIMILARITY: Belongs to the osteocalcin/matrix Gla protein family. PMID:9916809 The modified glutamic acid residues of Gla proteins confer a high affinity for mineral ions such as calcium, phosphate and hydroxyapatite crystals, the mineral components of the skeletal ECM. file:human/MGP/MGP-deep-research-perplexity.md The protein contains five glutamic acid residues that undergo gamma-carboxylation, converting them to gamma-carboxyglutamic acid (Gla) residues, which are responsible for the protein's high-affinity binding to calcium ions... The Gla residues of the carboxylated MGP bind positively charged calcium ions through electrostatic interactions, effectively sequestering calcium that would otherwise participate in hydroxyapatite formation
GO:0005576 extracellular region	IEA GO_REF:0000120	KEEP AS NON CORE	Summary: MGP is a secreted protein that functions in the extracellular region. While this annotation is correct, it is too general. The more specific term GO:0031012 (extracellular matrix) better describes MGP's primary functional localization. Reason: This is a valid but overly general localization annotation. MGP is indeed secreted to the extracellular region, but its specific functional location is the extracellular matrix where it associates with bone and cartilage. The more specific GO:0031012 term is already present and should be prioritized. This broader term adds little additional functional information. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted.
GO:0030154 cell differentiation	IEA GO_REF:0000043	KEEP AS NON CORE	Summary: This is an overly general parent term for all cell differentiation processes. While MGP does play roles in osteoblast and chondrocyte differentiation, this broad annotation provides minimal informative functional detail. More specific terms like GO:0001502 (cartilage condensation) are more appropriate. Reason: This annotation is technically correct but too general to be useful. MGP has documented roles in promoting osteoblast differentiation via Wnt signaling and in chondrocyte function, but annotating to this high-level parent term obscures the specific biological context. The more specific developmental terms already present (cartilage condensation, cartilage development) provide better functional annotation. Supporting Evidence: file:human/MGP/MGP-deep-research-perplexity.md In skeletal tissues, MGP functions as a positive regulator of osteoblast differentiation and bone formation... overexpression of MGP in osteoblast-like cells promotes cell proliferation, differentiation, and mineralization
GO:0030500 regulation of bone mineralization	IEA GO_REF:0000002	MODIFY	Summary: MGP is a critical negative regulator of mineralization, primarily functioning to inhibit ectopic calcification in soft tissues including cartilage and blood vessels. However, the term "bone mineralization" may be too narrow as MGP's primary role is preventing vascular and cartilage calcification rather than regulating bone mineralization per se. Reason: While MGP does regulate mineralization processes, the current term focuses on "bone mineralization" which does not capture MGP's primary function of preventing ectopic calcification in soft tissues. MGP's most critical role is as an inhibitor of vascular calcification and inappropriate cartilage calcification. The more specific term GO:0140928 "inhibition of non-skeletal tissue mineralization" precisely describes this function. Proposed replacements: inhibition of non-skeletal tissue mineralization Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. PMID:9916809 Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification... Mglap-deficient mice (Mglap-/-) have been reported to have inappropriate calcification of cartilage. file:human/MGP/MGP-deep-research-perplexity.md The primary and best-characterized function of MGP is its role as a potent, local inhibitor of pathological mineralization in soft tissues... mice lacking MGP die within two months of birth due to widespread arterial calcification and subsequent arterial rupture... MGP-deficient mice develop massive and widespread arterial calcification
GO:0031012 extracellular matrix	IEA GO_REF:0000002	ACCEPT	Summary: Duplicate annotation of GO:0031012 with different evidence code (IEA from InterPro domain mapping). MGP localizes to the extracellular matrix. Reason: Duplicate of the IBA annotation already reviewed. The IEA evidence is from InterPro domain IPR027118 (MGP family domain), which confirms the localization. Duplicates with different evidence codes are acceptable in GO annotation. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. FUNCTION: Associates with the organic matrix of bone and cartilage.
GO:0048731 system development	IEA GO_REF:0000117	KEEP AS NON CORE	Summary: This is an extremely broad parent term covering all system development processes. While MGP does play roles in skeletal system development and cardiovascular development, this annotation is far too general to provide useful functional information. Reason: This annotation was assigned by ARBA machine learning and represents a very high-level parent term in the biological process ontology. MGP has documented roles in cartilage development and skeletal system development, but annotating to this extremely general term provides minimal information about MGP's specific biological functions. More specific child terms like GO:0051216 (cartilage development) and GO:0001502 (cartilage condensation) are already present and much more informative. Supporting Evidence: file:human/MGP/MGP-deep-research-perplexity.md MGP is expressed in bone, cartilage, heart, and kidney... In the vasculature, MGP is synthesized by vascular smooth muscle cells (VSMCs)... MGP is abundantly expressed during developmental stages by chondrocytes in the growth plate
GO:0051216 cartilage development	IEA GO_REF:0000043	ACCEPT	Summary: MGP plays a critical role in cartilage development by preventing aberrant calcification of cartilage during development. This is a core function of MGP in skeletal tissues and is strongly supported by genetic and phenotypic evidence. Reason: This annotation accurately captures a core function of MGP. Loss of MGP function in Keutel syndrome results in abnormal cartilage calcification, demonstrating that MGP is essential for proper cartilage development. MGP is expressed by chondrocytes in the growth plate during developmental stages and associates with cartilage matrix. This is a specific and informative annotation that should be retained as a core function. Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. DISEASE: Keutel syndrome (KTLS) [MIM:245150]: An autosomal recessive disorder characterized by abnormal cartilage calcification PMID:9916809 Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and midfacial hypoplasia... Mglap-deficient mice (Mglap-/-) have been reported to have inappropriate calcification of cartilage. file:human/MGP/MGP-deep-research-perplexity.md MGP is abundantly expressed during developmental stages by chondrocytes in the growth plate and by osteoblasts in bone tissue, suggesting developmental roles beyond calcification inhibition
GO:0005201 extracellular matrix structural constituent	RCA PMID:23979707 SILAC-based proteomics of human primary endothelial cell mor...	MARK AS OVER ANNOTATED	Summary: MGP associates with the organic matrix of bone and cartilage and contributes to the structural organization of the extracellular matrix. However, MGP's primary molecular function is calcium ion binding (GO:0005509), not structural support. This annotation may represent an over-annotation based on MGP's presence in ECM proteomics studies. Reason: While MGP is present in the extracellular matrix and binds to matrix proteins like fibronectin and vitronectin, its primary molecular function is not to provide structural support. MGP's core function is calcium ion binding to inhibit calcification, not serving as a structural constituent. This RCA annotation likely derives from proteomics identification of MGP in ECM samples, but presence in the ECM does not necessarily indicate a structural role. Many small regulatory proteins in the ECM (like growth factors and BMP antagonists) are not structural constituents. Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. file:human/MGP/MGP-deep-research-perplexity.md Matrix Gla protein is a small secretory protein with a molecular weight of approximately 11-15 kilodaltons, composed of 84 amino acids... The primary and best-characterized function of MGP is its role as a potent, local inhibitor of pathological mineralization PMID:23979707 Epub 2013 Aug 26. SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.
GO:0005201 extracellular matrix structural constituent	RCA PMID:27068509 Extracellular matrix remodelling in response to venous hyper...	MARK AS OVER ANNOTATED	Summary: Duplicate GO:0005201 annotation from different proteomics study of extracellular matrix proteins in varicose veins. Reason: Same as previous GO:0005201 review - this is an over-annotation. MGP's primary molecular function is calcium ion binding, not serving as a structural constituent of the ECM. Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. PMID:27068509 Apr 11. Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.
GO:0005201 extracellular matrix structural constituent	RCA PMID:27559042 Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin...	MARK AS OVER ANNOTATED	Summary: Duplicate GO:0005201 annotation from glycoproteomics study. Reason: Same as previous GO:0005201 review - this is an over-annotation. MGP's primary molecular function is calcium ion binding, not serving as a structural constituent of the ECM. Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. PMID:27559042 Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.
GO:0005201 extracellular matrix structural constituent	RCA PMID:20551380 Proteomics characterization of extracellular space component...	MARK AS OVER ANNOTATED	Summary: Duplicate GO:0005201 annotation from proteomics study of aortic extracellular space. Reason: Same as previous GO:0005201 review - this is an over-annotation. MGP's primary molecular function is calcium ion binding, not serving as a structural constituent of the ECM. Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. PMID:20551380 2010 Jun 15. Proteomics characterization of extracellular space components in the human aorta.
GO:0031012 extracellular matrix	HDA PMID:27068509 Extracellular matrix remodelling in response to venous hyper...	ACCEPT	Summary: Duplicate GO:0031012 annotation with HDA evidence from proteomics study of varicose vein extracellular matrix. Confirms MGP localization to ECM. Reason: This HDA evidence from proteomics provides direct experimental support for MGP localization to the extracellular matrix. Duplicates with different evidence codes are acceptable in GO annotation and provide independent confirmation of the localization. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. PMID:27068509 Apr 11. Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.
GO:0031012 extracellular matrix	HDA PMID:27559042 Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin...	ACCEPT	Summary: Duplicate GO:0031012 annotation with HDA evidence from glycoproteomics study. Confirms MGP localization to ECM. Reason: Independent HDA evidence from different proteomics study confirming ECM localization. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. PMID:27559042 Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.
GO:0031012 extracellular matrix	HDA PMID:20551380 Proteomics characterization of extracellular space component...	ACCEPT	Summary: Duplicate GO:0031012 annotation with HDA evidence from aortic proteomics study. Confirms MGP localization to ECM. Reason: Independent HDA evidence from aortic extracellular space proteomics confirming ECM localization. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. PMID:20551380 2010 Jun 15. Proteomics characterization of extracellular space components in the human aorta.
GO:0031012 extracellular matrix	HDA PMID:23979707 SILAC-based proteomics of human primary endothelial cell mor...	ACCEPT	Summary: Duplicate GO:0031012 annotation with HDA evidence from endothelial cell proteomics. Confirms MGP localization to ECM. Reason: Independent HDA evidence from endothelial morphogenesis proteomics confirming ECM localization. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. PMID:23979707 Epub 2013 Aug 26. SILAC-based proteomics of human primary endothelial cell morphogenesis unveils tumor angiogenic markers.
GO:0005515 protein binding	IPI PMID:15607035 Systematic identification of hepatocellular proteins interac...	REMOVE	Summary: This annotation is based on a yeast two-hybrid screen for hepatitis C virus NS5A protein interactions, which is not relevant to MGP's physiological function. While MGP does bind to proteins like BMP-2/4/7, fibronectin, and vitronectin, this non-specific "protein binding" term provides no useful functional information. Reason: This annotation should be removed for two reasons. First, the reference (PMID:15607035) is a study identifying hepatocellular proteins interacting with hepatitis C virus NS5A protein - this is not relevant to MGP's normal biological function. Second, even if MGP does bind proteins (which it does - BMPs, fibronectin, vitronectin), the term "protein binding" is too general to provide any functional insight. More specific terms like "BMP binding" would be appropriate if supported by direct evidence, but generic "protein binding" should be avoided as per curation guidelines. Supporting Evidence: PMID:15607035 The hepatitis C virus is associated with the development of liver cirrhosis and hepatocellular carcinomas... Yeast two-hybrid experiments were performed with a human liver cDNA prey-library, using five different NS5A derivatives as baits [this is not about MGP's normal function]
GO:0070062 extracellular exosome	HDA PMID:19199708 Proteomic analysis of human parotid gland exosomes by multid...	KEEP AS NON CORE	Summary: MGP was detected in extracellular exosomes from human parotid gland by proteomics analysis. While MGP can be found in exosomes, this is likely an incidental finding rather than indicating a primary functional localization. MGP's main functional location is the extracellular matrix. Reason: This annotation is based on HDA evidence from proteomics identification of MGP in parotid gland exosomes. While technically correct, exosome localization is not a core functional location for MGP. Many secreted proteins can be found in exosomes as a byproduct of secretion pathways. MGP's primary and functionally relevant localization is the extracellular matrix of bone, cartilage, and vascular tissues where it inhibits calcification. This annotation should be kept as non-core to reflect that while MGP can be detected in exosomes, this is not its primary site of action. Supporting Evidence: file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. FUNCTION: Associates with the organic matrix of bone and cartilage. PMID:19199708 Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).
GO:0001502 cartilage condensation	TAS PMID:9916809 Mutations in the gene encoding the human matrix Gla protein ...	ACCEPT	Summary: MGP plays a role in cartilage condensation, a specific early stage of cartilage development where mesenchymal cells aggregate. This annotation is supported by TAS evidence from the Keutel syndrome paper demonstrating MGP's importance in cartilage development. Reason: This is a specific and informative annotation supported by strong genetic evidence. Cartilage condensation is the process by which mesenchymal cells aggregate and differentiate into chondrocytes, initiating cartilage formation. The Keutel syndrome phenotype demonstrates that loss of MGP function results in abnormal cartilage calcification, indicating MGP's critical role in proper cartilage development including the condensation stage. This is more specific than the general "cartilage development" term and should be retained as a core function. Supporting Evidence: PMID:9916809 Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification, peripheral pulmonary stenosis and midfacial hypoplasia... Mglap-deficient mice (Mglap-/-) have been reported to have inappropriate calcification of cartilage. file:human/MGP/MGP-deep-research-perplexity.md MGP is abundantly expressed during developmental stages by chondrocytes in the growth plate and by osteoblasts in bone tissue
GO:0001503 ossification	TAS PMID:9916809 Mutations in the gene encoding the human matrix Gla protein ...	ACCEPT	Summary: Duplicate GO:0001503 annotation with TAS evidence from the Keutel syndrome paper. This provides stronger experimental support than the IEA annotation. Reason: This is a duplicate of the earlier IEA annotation but with stronger TAS evidence from PMID:9916809, the seminal paper identifying MGP mutations as the cause of Keutel syndrome. The TAS evidence code indicates a traceable author statement, which is more reliable than IEA computational inference. The annotation is appropriate as discussed in the earlier review of GO:0001503. Supporting Evidence: PMID:9916809 Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification... The pattern and tissue distribution of Mgp expression in mice suggest a role for Mgp in regulating ECM calcification.
GO:0005201 extracellular matrix structural constituent	TAS PMID:9916809 Mutations in the gene encoding the human matrix Gla protein ...	MARK AS OVER ANNOTATED	Summary: Duplicate GO:0005201 annotation with TAS evidence from the Keutel syndrome paper. However, as with the RCA annotations, this represents an over-annotation of MGP's molecular function. Reason: While this TAS evidence from the authoritative Keutel syndrome paper provides strong support, it does not change the fundamental assessment that "extracellular matrix structural constituent" is an over-annotation of MGP's molecular function. MGP's primary molecular function is calcium ion binding (GO:0005509), not providing structural support to the ECM. The paper describes MGP as a "skeletal extracellular matrix (ECM) protein" because it is found in the ECM, not because it serves a structural role. As a small 11-15 kDa regulatory protein, MGP's function is to inhibit calcification, not to provide mechanical structure like collagens, elastin, or proteoglycans. Supporting Evidence: PMID:9916809 Human MGP is a 10-kD skeletal extracellular matrix (ECM) protein that consists of an 84-aa mature protein... The modified glutamic acid residues of Gla proteins confer a high affinity for mineral ions such as calcium, phosphate and hydroxyapatite crystals
GO:0008147 structural constituent of bone	TAS PMID:9916809 Mutations in the gene encoding the human matrix Gla protein ...	MARK AS OVER ANNOTATED	Summary: This annotation assigns MGP a structural role specifically in bone. However, like GO:0005201, this represents an over-annotation. MGP's primary molecular function is calcium ion binding for calcification inhibition, not providing structural support to bone tissue. Reason: While MGP associates with bone matrix and is found in bone tissue, this does not make it a "structural constituent" in the functional sense intended by this GO term. Structural constituents of bone include proteins like collagen type I, osteocalcin (in the mineralized phase), and osteonectin that provide mechanical properties and scaffolding. MGP is a small regulatory protein (11-15 kDa) whose function is to inhibit inappropriate calcification through calcium binding, not to contribute to bone's structural integrity. Moreover, MGP functions primarily in cartilage and vascular tissues rather than being bone-specific. This annotation conflates presence in bone with structural function. Supporting Evidence: file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. file:human/MGP/MGP-deep-research-perplexity.md Matrix Gla protein is a small secretory protein with a molecular weight of approximately 11-15 kilodaltons... The primary and best-characterized function of MGP is its role as a potent, local inhibitor of pathological mineralization in soft tissues PMID:9916809 Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome.
GO:0031012 extracellular matrix	TAS PMID:9916809 Mutations in the gene encoding the human matrix Gla protein ...	ACCEPT	Summary: Final duplicate of GO:0031012 annotation, with TAS evidence from the authoritative Keutel syndrome paper. Provides strong experimental support for MGP's ECM localization. Reason: This is another duplicate of the GO:0031012 annotation, but with the strongest evidence type (TAS from the seminal Keutel syndrome paper). This provides definitive support for MGP's localization to the extracellular matrix. As discussed in previous reviews, this is MGP's primary functional localization and represents a core annotation. Multiple evidence codes for the same term are acceptable and provide independent confirmation. Supporting Evidence: PMID:9916809 Human MGP is a 10-kD skeletal extracellular matrix (ECM) protein... The pattern and tissue distribution of Mgp expression in mice suggest a role for Mgp in regulating ECM calcification. file:human/MGP/MGP-uniprot.txt SUBCELLULAR LOCATION: Secreted. FUNCTION: Associates with the organic matrix of bone and cartilage.
GO:0140928 inhibition of non-skeletal tissue mineralization	NAS file:human/MGP/MGP-deep-research-perplexity.md	NEW	Summary: MGP's primary and best-characterized function is inhibition of pathological mineralization in non-skeletal soft tissues, particularly vascular tissue and cartilage. This term precisely captures MGP's core biological function. Reason: This annotation should be added as it accurately describes MGP's primary biological function. While GO:0030500 (regulation of bone mineralization) exists in the current annotations, it does not accurately capture that MGP's main role is preventing ectopic calcification in soft tissues rather than regulating bone mineralization. The term GO:0140928 "inhibition of non-skeletal tissue mineralization" was created specifically for proteins like MGP that prevent inappropriate calcification outside of skeletal tissues. This is strongly supported by the MGP knockout mouse phenotype (massive arterial calcification leading to death) and the Keutel syndrome phenotype (abnormal cartilage and vascular calcification). Supporting Evidence: file:human/MGP/MGP-deep-research-perplexity.md The primary and best-characterized function of MGP is its role as a potent, local inhibitor of pathological mineralization in soft tissues, particularly in the vasculature and cartilage... mice lacking MGP die within two months of birth due to widespread arterial calcification and subsequent arterial rupture... MGP-deficient mice develop massive and widespread arterial calcification PMID:9916809 Keutel syndrome (KS, MIM 245150) is an autosomal recessive disorder characterized by abnormal cartilage calcification... Mglap-deficient mice (Mglap-/-) have been reported to have inappropriate calcification of cartilage. file:human/MGP/MGP-uniprot.txt FUNCTION: Associates with the organic matrix of bone and cartilage. Thought to act as an inhibitor of bone formation. PMID:38931153 the matrix Gla protein (MGP) serves as both a potent inhibitor of VC and a valuable biomarker (in its inactive form) for reflecting circulating vitamin K levels.
GO:0036122 BMP binding	NAS file:human/MGP/MGP-deep-research-falcon.md	NEW	Summary: MGP binds BMP-2 and BMP-4 in a Ca2+/Gla-dependent manner, acting as a BMP antagonist. This direct binding to BMP ligands is a well-established mechanism by which MGP suppresses osteogenic signaling in the vascular wall, distinct from its mineral-binding function. The falcon deep research synthesizes multiple sources converging on this mechanism. Reason: BMP binding is a core, mechanistically distinct molecular function of MGP that is not represented in the existing annotations. Multiple recent reviews converge on a dual-mechanism model in which MGP both (i) binds Ca2+/hydroxyapatite to control the mineral phase directly, and (ii) binds BMP-2/4 to antagonize osteogenic signaling. The binding is explicitly Ca2+/Gla-dependent, providing biochemical specificity. This annotation captures the molecular interaction that underlies the signaling-control arm of MGP's anti-calcification activity. Supporting Evidence: file:human/MGP/MGP-deep-research-falcon.md MGP is repeatedly described as binding BMP-2 (and BMP-4) and blocking osteogenic signaling in vascular tissues. file:human/MGP/MGP-deep-research-falcon.md Structural/biophysical evidence summarized in 2025 emphasizes Ca2+/Gla dependence for BMP binding (BMP-2/4) and highlights that Gla/Ca2+ chemistry is required for this antagonism.
GO:0030514 negative regulation of BMP signaling pathway	NAS file:human/MGP/MGP-deep-research-falcon.md	NEW	Summary: Through direct binding of BMP-2/4, MGP antagonizes BMP-driven osteogenic/chondrogenic transdifferentiation of vascular smooth muscle cells, thereby suppressing a major signaling route to vascular calcification. This is a distinct biological process from direct mineral binding and is part of MGP's dual anti-calcification mechanism. Reason: This biological process annotation complements the BMP binding molecular function and captures the signaling-pathway consequences of MGP's BMP antagonism. Recent reviews emphasize that MGP suppresses BMP-driven osteogenic conversion of vascular smooth muscle cells, limiting apoptosis-linked calcification. This pathway-level role is not captured by the existing mineralization annotations. Supporting Evidence: file:human/MGP/MGP-deep-research-falcon.md MGP binds BMP-2 and BMP-4 in a Ca²⁺/Gla-dependent manner and blocks BMP-driven osteogenic/chondrogenic conversion of vascular smooth muscle cells, thereby suppressing a key signaling route to vascular calcification. file:human/MGP/MGP-deep-research-falcon.md Signaling control: MGP antagonizes BMP-2/4 to prevent osteogenic transdifferentiation in the vessel wall.

Gene Description

Existing Annotations Review

Core Functions

calcium ion binding activity that inhibits pathological mineralization in vascular and cartilage tissues

calcium ion binding activity that regulates cartilage condensation and development during skeletogenesis

calcium ion binding activity that regulates ossification through context-dependent mechanisms including inhibition of ectopic bone formation and promotion of osteoblast differentiation via Wnt signaling

BMP-2/4 binding and antagonism of BMP signaling, which prevents osteogenic transdifferentiation of vascular smooth muscle cells and contributes to suppression of vascular calcification independently of direct mineral binding

References

Deep Research

Falcon

OpenAI

Perplexity

Perplexity

📄 View Raw YAML